ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,247, issued on May 20, was assigned to University of North Texas Health Science Center at Fort Worth (Fort Worth, Texas).
"Methods and tools for diagnosing insulin resistance and assessing health status using NMR relaxation times for water" was invented by David P. Cistola (El Paso, Texas) and Michelle D. Robinson (Dallas).
According to the abstract* released by the U.S. Patent & Trademark Office: "The subject invention pertains to a method that involves at least three steps: (1) acquisition of a NMR data set or spin relaxation curve for plasma, serum or whole blood samples, (2) analysis of the NMR data or relaxation curve to extract the T2 relaxation times for water (or surrogat...